The downward trend in IL-18 post-treatment could suggest that metformin helps to partially alleviate inflammasome-driven inflammation in PCOS, which has also been supported by other research showing metformin’s ability to modulate IL-18 levels in conditions of insulin resistance and metabolic dysfunction [19]. Here, IL18 is linked to polycystic ovary syndrome.